Clinical Trials List
Protocol NumberNS863B-P2-01
Not yet recruiting
2026-07-01 - 2029-12-31
Phase II
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 侯鈞賀 Division of Ophthalmology
- 郭耀文 Division of Thoracic Medicine
- YEN-HUNG LIN Division of Cardiovascular Diseases
Co-Principal Investigator
- Jia-Yih Feng Division of Thoracic Medicine
- 張皓智 Division of Cardiovascular Diseases
- 游偉光 Division of Ophthalmology
- Kang-Ling Wang 臨床試驗科
- Wei-Zhi Chen Division of Thoracic Medicine
- 蕭逸函 Division of Thoracic Medicine
Co-Principal Investigator
- Hung-Ling Huang Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- Po-Chao Hsu Division of Cardiovascular Diseases
- Wei-An Chang Division of Thoracic Medicine
- 李岱晃 Division of Thoracic Medicine
- 吳韋璁 Division of Cardiovascular Diseases
- Ming-Ju Tsai Division of Thoracic Medicine
- jong rung Tsai Division of Thoracic Medicine
- 黃天祈 Division of Cardiovascular Diseases
- 鄭孟軒 Division of Thoracic Medicine
- 鄭至宏 Division of Thoracic Medicine
- Chun-Yuan Chu Division of Cardiovascular Diseases
Co-Principal Investigator
- 吳書豪 Division of Cardiovascular Diseases
Co-Principal Investigator
- 王振宇 Division of Thoracic Medicine
- WEI-WEN LIN Division of Cardiovascular Diseases
- 陳昱瑋 Division of Cardiovascular Diseases
- 蕭亦均 Division of Thoracic Medicine
- 黃丞正 Division of Thoracic Medicine
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
177 participants
